Mario Negri Institute for Pharmacological Research: Polycystic Kidney, Autosomal Dominant trials

The registry lists 10 Polycystic Kidney, Autosomal Dominant studies with Mario Negri Institute for Pharmacological Research as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare DiseasesRecruitingNCT05996731Not applicable
• Simulated and Synthetic Health Data: Improving Clinical Research on Rare Diseases. A Real-World Data Simulation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trials. A Retrospective, Observational StudyActive, not recruitingNCT07016282
• Artificial Intelligence-based Image Processing Methods to Advance the Characterization of Polycystic Kidney DiseaseActive, not recruitingNCT06688981
• A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo ProvinceCompletedNCT06594367
• Outcome of ADPKD With Octreotide LARActive, not recruitingNCT06193616
• Thyroid Hormones in ADPKDCompletedNCT05646420Not applicable
• Tolvaptan-Octreotide LAR Combination in ADPKDCompletedNCT03541447Phase 2
• Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal InsufficiencyCompletedNCT01377246Phase 3
• Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal InsufficiencyTerminatedNCT01223755Phase 2/3
• Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up StudyCompletedNCT00309283Phase 3